About the Book:
This book is a collection of research papers by Germán Velásquez published by the South Centre, between 2015 and 2019 on the recent international deliberations and negotiations in the United Nations on access to medicines and their relationship with international trade and intellectual property regimes.
The book analyses the patentability criteria of pharmaceutical products, the international debate on generic medicines of biological origin and the access to hepatitis C treatment, in particular. The South Centre is an intergovernmental research organization of developing countries on critical development issues for the South and is an observer to the governing bodies of the World Health Organization (WHO) and other United Nations (UN) agencies. It is hoped that the collection of papers presented in this book will be useful for policy makers and researchers interested in the deliberations in UN and WHO, in particular, on the critical issues pertaining to public health and access to medicines.
About the Author:
Dr. Germán Velásquez is Special Health and Policy Advisor to the Executive Director of the South Centre in Geneva, Switzerland. Previously he was Director of the Secretariat on Public Health, Innovation and Intellectual Property at the World Health Organization. He represented WHO at the WTO TRIPS Council from 2001 to 2010. He is the author and co-author of numerous publications on health economics and medicines, health insurance schemes, globalization, international trade agreements, intellectual property and access to medicines.